- Review
27 October 2026
Background: Evaluating multidimensional value in chronic lymphocytic leukemia (CLL) is complicated by distinct endpoint hierarchies, patient heterogeneity, therapeutic resistance mechanisms, and healthcare costs. Consequently, addressing these multif...